PCI or CABG: Which patients and at what cost?

Heart

Volumn 93, Issue 10, 2007, Pages 1188-1190

  Gershlick, Tony ^b   Thomas, Martyn ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPLASTY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; HEART LEFT VENTRICLE FAILURE; HUMAN; INTERMETHOD COMPARISON; ISCHEMIA; MEDICAL RESEARCH; META ANALYSIS; NON INVASIVE PROCEDURE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SHORT SURVEY; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; COST-BENEFIT ANALYSIS; HUMANS;

EID: 34848832931     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.124750     Document Type: Short Survey

References (18)

1. 1 BCIS. British Cardiovascular Intervention Society PCI audit. Available at http://www.bcis.org.uk/resources/audit (accessed 12 June 2007).
2. Bowden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-16.
3. David P Taggart. Coronary revascularisation. BMJ 2007;334:593-4.
4. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005;352:2174-83.
5. Brener SJ, Lytle BW, Casserly IP, et al. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 2004;109:2290-5.
6. Hoffman SN, TenBrook JA, Wolf MP, et al. A meta-analysis of randomised trials comparing coronary artery bypass grafting with percutaneous coronary angioplasty: one to eight year outcomes. J Am Coll Cardiol 2003;41:1293-304.
7. Goyal A, Alexander JH, Hafley GE, et al. Outcomes associated with the use of secondary prevention medications after coronary artery bypass surgery. Ann Thorac Surg 2007;83:993-1001.
8. Rodriquez AE, Baldi J, Fernandez Pereira C, et al. Five-year follow-up of the Argentine randomised trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multivessel disease (ERACI II). J Am Coll Cardiol 2005;46:582-8.
9. Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularisation Therapies Study (ARTS) randomised trial. J Am Coll Cardiol 2005;46:575-81.
10. Hueb W, Lopes NH, Gersh BJ, et al. Five year follow up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomised controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007;115:1082-9.
11. Mercado N, Wijns W, Serruys PW, et al. One year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 2005;130:512-9.
12. Rodriguez AE, Mieres, Fernandez-Pereira C, et al. Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial. J Am Coll Cardiol 2006;47:205-7.
13. Tsuchida K, Colombo A, Lefevre T, et al. The clinical outcome of percutaneous treatment of bifurcation lesions in the multivessel coronary artery disease with sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study part II (ARTS II). Eur Heart J 2007;28:433-42.
14. Ong AT, Serruys PW, Mohr FW, et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 2006;151:1194-204.
15. Griffin SC, Barber JA, Manca A, et al. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ 2007;334:624-8.
16. Aziz O, Rao C, Panesar SS, et al. Meta-analysis of minimally invasive internal thoracic artery bypass versus percuataneous revascularisation for isolated lesions of the left anterior descending artery. BMJ 2007;334:617-21.
17. Rao C, Aziz O, Panesar SS, et al. Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery. BMJ 2007;334:621-4.
18. Weintraub WS, Mahoney EM, Zhang Z, et al. One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial. Heart 2004;90:782-8.